Simplicity built in. Streamlined for your laboratory.

The Alinity h-series of systems integrates hematology workflow, from high-throughput Complete Blood Count (CBC) analysis to automated slide making and staining. With a bi-directional, internal conveyor and a throughput of 125 CBCs per m2, it delivers high performance in one of the most compact footprints available.

The system is composed of two Alinity hq modules and an Alinity hs module in a hq-hs-hq configuration. The Alinity hq analyzer delivers a CBC with an expanded 6-part White Blood Cell (WBC) differential that includes routine and several advanced parameters using Advanced MAPSS (Multi Angle Polarized Scatter Separation) technology. With the Alinity hs slide maker stainer and the integrated robotic sample management, the Alinity h-series of systems delivers unprecedented uniformity, flexibility, operational productivity and confidence to your customers.

Achieve integration that is built on user-focused design

With an emphasis on addressing needs articulated by you, the Alinity h-series of solutions offer an intuitive and uniform experience, aligned with other Alinity solutions. This commonality in user experience across multiple laboratory disciplines, allows for efficiencies in training, operation, and utilization of staff.

Deliver performance that comes from proven expertise in system and assay design

The Alinity h-series was designed from the ground-up with innovative technology and design elements that will address your need of managing a changing workload with existing resources. Alinity hq and Alinity hs have been designed to help you improve your laboratory’s operational productivity by automating routine processes, allowing your staff to focus on critical tasks.

Not commercially available in all countries, including the USA.

For invitro diagnostics use only.

ADD-00062367
Read more

Recently launched is a high-performance real-time PCR assay: Meningitis Viral 2 ELITe MGB Panel for viral meningitis diagnosis, validated with ELITe InGenius, ELITechGroup’s fully automated sample to result system. Viruses are the most common causative agent of meningitis. Although presenting similar onset, viral and bacterial meningitis are associated with entirely different outcomes. Rapid and accurate diagnosis by molecular method is important to identify the viral agent, rule out a bacterial infection, and adapt patient management. Meningitis Viral ELITe MGB Panel 2 is a multiplex assay validated with cerebrospinal fluid samples, which combines reverse transcription and real-time PCR amplification for the detection and the differentiation of Enterovirus, Parechovirus and Adenovirus in one single reaction. The clinical studies have demonstrated excellent performance: 100% diagnostic sensitivity and 100% specificity for all targets. The validation with the ELITe InGenius system offers several advantages to laboratories: results in only 2h30 with limited hands-on time, emergency testing performed in parallel of any routine samples within the same run, and storage of extracted nucleic acid for an optimal use of precious CSF samples for retesting, additional molecular testing, or archiving. The ELITe InGenius menu for molecular diagnosis of meningitis will be further broadened in the coming months, with an additional real-time PCR multiplex assay for the detection of the main causative agents of bacterial meningitis.

Read more

Anti-CCP is the marker of choice among rheumatologists for aid in the serological diagnosis of rheumatoid arthritis (RA). For over 15 years Axis-Shield has been a major pioneer developing this marker on a number of different technologies and is now making available the first anti-CCP test designed for use on open clinical chemistry systems. With excellent clinical specificity and sensitivity for patients with RA, results can be received in 10 minutes. This latex-enhanced immunoturbidimetric test is suitable for use with either serum or plasma. This methodology will allow laboratories to consolidate their testing along with other acute phase reactants and serological markers associated with rheumatic diseases. Each reagent pack supplied has 100 tests. Controls and calibrators are available separately.

Read more

The cobas m 511 combines a digital morphology analyser, cell counter and classifier into one streamlined instrument preparing, staining and analysing microscopy blood slides. By counting, identifying, isolating and categorizing white blood cells, red blood cells and platelets and finally presenting the digital images of all these cell types on the Viewing Station including a standard CBC and 5-part differential, the cobas m 511 helps medical technologists concentrate on finding and classifying abnormal cells within a patient sample. Significantly, the cobas m 511 requires only small sample volumes, so the blood requirements from vulnerable groups such as the elderly, intensive care patients and neonates are greatly reduced. The Bloodhound technology represents the core intelligence of the cobas m 511.  It analyses the morphology of individual cells and presents the results of the analysis in detailed images for human interaction. Moreover, while medical technologists will continue to have the option of looking at slides under their microscopes, Bloodhound technology provides cell-by-cell images that, in many cases, may eliminate the need for microscopic review. As opposed to the typical indirectly measured approaches used in blood analysis today – primarily impedance and flow cytometry – the Bloodhound technology images individual cells directly, analyses each cell’s morphology, counts it, and then classifies all the cells in the viewing area to provide a CBC, 5-part differential, and reticulocyte count. The cobas m 511 integrated hematology analyser has several quality control features built into the graphical user interface (GUI) software that are designed to help to reduce subjectivity of cell identification and standardize the quality of the results, sample after sample. The analyser uses the DigiMAC3 stain pack for a fully automated fix and stain of the microscopy slide and will process 1,000 cycles without replacement. Thanks to an internal reservoir, the analyser holds enough reserve reagents to process 25 samples after the DigiMAC3 stain pack empties. Using a proprietary “hot swap” process, technicians can quickly change the DigiMAC3 stain pack while the instrument is still processing specimens. An integrated Viewing Station provides medical technologists and hematologists with cell-by-cell viewing access. Going beyond what would normally be seen in a field-of-view through a microscope, Bloodhound technology allows to view individual white blood cells (WBCs), red blood cells (RBCs) and platelets on a high-resolution display and organizes them into cell-specific galleries. It also allows to sort RBCs by size, shape and hemoglobin concentration as well as platelets by size and granularity. All cell images from the various galleries can be enlarged to ensure an even closer examination of the cell’s structure and morphology. Most importantly, the Bloodhound technology identifies and isolates abnormal white cells from the population of the non-pathological white cells. These are any cells that cannot be classified due to morphologic or abnormal aberrations and require review by the medical technologist or hematologist.

Read more

The DuraClone RE* antibody panels provide tools to study low frequency populations of either abnormal CD5+ B cells (RE CLB), abnormal plasma cells (RE PC) or abnormal B progenitor cells (RE ALB). The three new standardized, pre-formulated DuraClone RE* kits deliver high sensitivity for rare cell populations, able to accommodate either large sample volumes or high cellular concentrations. Using dry, unitized antibody combinations helps preserve the strict assay conditions essential for reliable, reproducible rare event analysis. The DuraClone family of dry reagents simplifies sample preparation and handling.  The panels eliminate errors from manual antibody pipetting, streamline workflow, improve turnaround time (TAT) and simplify inventory management. The kits are stable at room temperature, even when opened, and easy to transfer between laboratories. The first Duraclone standardized dry, pre-formulated panels were introduced in 2014, to support research into the human immune system.  Since then, the company has added DuraClone IM and IF panels for investigating immune profiles and function. While preserving strict assay conditions, which is integral to rare event analysis, the DuraClone RE* kits, produced in collaboration with experts from leading clinical research laboratories, enable streamlined workflow and standardization of results that are essential to the experimental robustness of longitudinal and multi-centric research into blood disorders. Internationally-recognized German clinical research scientists commented that the inclusion in the DuraClone RE CLB panels of ROR-1 as a new discriminative marker has markedly facilitated the screening for low frequencies of abnormal B cells and also that the DuraClone Panels provide a sensitive, analytically reliable and economic tool for the detection of minute, abnormal, plasma cell populations. DuraClone RE antibody panels are available in a convenient 25-test package containing three complete compensation kits specific for each panel. They offer the flexibility of additional antibody drop-in slots, making it possible to answer a customer’s specific questions. Further additions to the DuraClone product family are in development, including dry stimulation cocktails for functional assays.

Read more